HubSpot
HUBS
$231.21
+3.10%
HubSpot provides a cloud-based marketing, sales, and customer service software platform, known as the growth platform, serving businesses of all sizes. As a pioneer in inbound marketing, HubSpot has evolved into a comprehensive customer relationship management (CRM) platform, competing with Salesforce and other SaaS giants. The stock is currently under intense scrutiny as it navigates a sharp drawdown from its 52-week high, with investors debating whether the recent revenue acceleration and profitability inflection justify a recovery or if macro headwinds and competitive pressures will persist. Recent news highlights a broader SaaS sector rotation, with HubSpot's Q1 2026 earnings showing improved profitability but ongoing concerns about growth sustainability.…
HUBS
HubSpot
$231.21
Related headlines
HUBS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on HubSpot's 12-month outlook, with a consensus price target around $275.72 and implied upside of +19.3% versus the current price.
Average Target
$275.72
0 analysts
Implied Upside
+19.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$180 - $450
Analyst target range
HubSpot is covered by 33 analysts, with a consensus recommendation of 'Buy' (mean rating 1.79 on a 1-5 scale). The average price target is $275.72, implying 22.9% upside from the current price of $224.26. The distribution shows 10 recent ratings actions: 6 Overweight/Buy, 3 Neutral, and 1 Market Perform, indicating a generally bullish but cautious sentiment. The high target of $450.00 represents a potential 100.6% upside, assuming a return to growth acceleration and multiple expansion, while the low target of $180.00 implies 19.8% downside, factoring in continued deceleration or margin compression. The wide spread between high and low targets ($270) reflects high uncertainty about HubSpot's future trajectory. Recent downgrades from Cantor Fitzgerald (Overweight to Neutral), Macquarie (Outperform to Neutral), and William Blair (Outperform to Market Perform) suggest some analysts are turning cautious, while Barclays, Morgan Stanley, and Wells Fargo maintain Overweight ratings. This mixed sentiment underscores the debate around the stock's recovery potential.
Bulls vs Bears: HUBS Investment Factors
HubSpot presents a classic value vs. growth debate. On the bull side, the company has achieved a profitability inflection, generating positive net income and strong free cash flow, while trading at a forward P/E of 14.3x—a deep discount to the software sector. The balance sheet is pristine with no debt and nearly $1 billion in cash. However, bears point to decelerating revenue growth (23.4% YoY, down from 27.5%), a trailing P/E of 456x that leaves no room for error, and a 57.6% stock decline over the past year. Recent analyst downgrades and a high short ratio add to the caution. The single most important tension is whether the profitability inflection can sustain and accelerate, justifying the forward multiple, or if revenue deceleration will force further multiple compression. Currently, the bear case has slightly stronger evidence given the growth deceleration trend, but the valuation discount provides a margin of safety.
Bullish
- Profitability Inflection Achieved: HubSpot reported net income of $32.6 million in Q1 2026, a significant turnaround from a $21.8 million loss in Q1 2025. This marks a clear profitability inflection, with net margin improving from -3.1% to 3.7%, demonstrating the company's ability to scale efficiently.
- Forward P/E Deeply Discounted: The forward P/E of 14.3x is a 59% discount to the software industry average of ~35x. This low multiple suggests the market is pricing in conservative expectations, creating potential upside if HubSpot sustains its earnings growth trajectory.
- Strong Free Cash Flow Generation: HubSpot generated $183.4 million in free cash flow in Q1 2026, a 23.7% increase year-over-year, with a free cash flow margin of 20.8%. This robust cash generation provides financial flexibility for investments or acquisitions.
- Healthy Balance Sheet with No Debt: The company holds $946.6 million in cash with no long-term debt, resulting in a debt-to-equity ratio of just 0.13. This strong liquidity position insulates HubSpot from macro shocks and supports organic growth initiatives.
Bearish
- Revenue Growth Deceleration Trend: Revenue growth has decelerated from 27.5% YoY in Q3 2025 to 23.4% in Q1 2026. This consistent deceleration raises concerns about market saturation and competitive pressure, potentially leading to further multiple compression.
- Extreme Trailing P/E of 456x: Despite the profitability inflection, the trailing P/E of 456x is extremely elevated. This leaves the stock vulnerable to any earnings miss, as the high multiple implies aggressive future expectations that may not materialize.
- Significant Underperformance vs Market: HubSpot has declined 57.6% over the past year, massively underperforming the S&P 500's 18.4% gain. The stock sits at only 39.5% of its 52-week range, indicating deep bearish sentiment and potential for further downside.
- Recent Analyst Downgrades Signal Caution: Cantor Fitzgerald, Macquarie, and William Blair have all downgraded HubSpot from Overweight/Outperform to Neutral/Market Perform. These downgrades reflect growing skepticism about the company's growth sustainability and margin trajectory.
HUBS Technical Analysis
HubSpot is in a pronounced downtrend, with the stock down 57.6% over the past year, significantly underperforming the S&P 500's 18.4% gain. The current price of $224.26 sits at 39.5% of its 52-week range (low $169.63, high $568.16), indicating deep bearish territory near the lower end. This positioning suggests the market has priced in substantial pessimism, but the stock has not yet confirmed a reversal pattern. Short-term momentum has improved dramatically, with a 1-month gain of 26.9% versus a 3-month gain of just 0.8%, signaling a sharp recovery from the June lows. This divergence from the 1-year downtrend could indicate a potential trend reversal or a dead-cat bounce, especially given the stock's beta of 1.22, which implies 22% more volatility than the market. The 52-week low of $169.63 serves as critical support, while resistance lies at the 52-week high of $568.16, a level that seems distant without a fundamental catalyst. A break above the recent high of $224.57 (previous close) would confirm short-term strength, while a drop below $170 would signal further downside. The stock's elevated short ratio of 3.12 suggests significant bearish sentiment, which could fuel a short squeeze if positive momentum continues.
Beta
1.22
1.22x market volatility
Max Drawdown
-69.6%
Largest decline past year
52-Week Range
$170-$568
Price range past year
Annual Return
-57.4%
Cumulative gain past year
| Period | HUBS Return | S&P 500 |
|---|---|---|
| 1m | +31.3% | -0.6% |
| 3m | +0.3% | +5.4% |
| 6m | -23.5% | +8.3% |
| 1y | -57.4% | +18.3% |
| ytd | -39.5% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HUBS Fundamental Analysis
HubSpot's revenue growth remains robust but decelerating, with Q1 2026 revenue of $881.0 million growing 23.4% year-over-year, down from 25.3% in Q4 2025 and 27.5% in Q3 2025. Subscription revenue of $862.3 million accounts for 97.9% of total revenue, while service revenue contributed $18.7 million. The growth trajectory, while slowing, still outpaces many SaaS peers, but the deceleration raises questions about market saturation and competitive pressure. Profitability has improved markedly, with Q1 2026 net income of $32.6 million (net margin 3.7%) versus a loss of $21.8 million in the year-ago quarter. Gross margin remains strong at 83.5%, consistent with historical levels, while operating margin turned positive at 3.3%, up from -3.8% in Q1 2025. This inflection to profitability is a key positive, but the absolute margin levels are still low for a SaaS company, indicating room for operating leverage. HubSpot's balance sheet is healthy, with $946.6 million in cash and no long-term debt, resulting in a debt-to-equity ratio of 0.13. Free cash flow was $183.4 million in Q1 2026, up from $148.2 million a year ago, representing a free cash flow margin of 20.8%. The company's ROE of 2.2% is low but improving, reflecting the recent profitability turnaround. The strong cash position and positive FCF provide financial flexibility for organic investments or M&A.
Quarterly Revenue
$880995000.0B
2026-03
Revenue YoY Growth
+23.4%
YoY Comparison
Gross Margin
83.5%
Latest Quarter
Free Cash Flow
$712466000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HUBS Overvalued?
Given HubSpot's positive net income of $32.6 million in Q1 2026, we lead with the P/E ratio. The trailing P/E of 456x is extremely elevated due to historically low earnings, but the forward P/E of 14.3x reflects a dramatic earnings expansion expected by analysts. This massive gap between trailing and forward multiples implies the market anticipates a step-change in profitability, which is supported by the recent earnings inflection. Compared to the software industry average P/E of approximately 35x, HubSpot's forward P/E of 14.3x appears deeply discounted, trading at a 59% discount. However, this comparison is misleading because the industry average includes many high-growth, high-multiple names; HubSpot's discount likely reflects its decelerating growth and the market's skepticism about sustained profitability. Historically, HubSpot's trailing P/E has ranged from negative (during loss-making periods) to over 800x, so the current forward multiple is near the low end of its historical range. This suggests the market is pricing in conservative expectations, which could present an opportunity if the company delivers on earnings estimates. The PEG ratio of 0.52x (based on forward earnings growth) indicates the stock is undervalued relative to its growth rate, but this metric relies on analyst estimates that may prove optimistic.
PE
456.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 96x~1742x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
87.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: HubSpot's primary financial risk is its reliance on continued revenue growth to justify its valuation. Revenue growth decelerated from 27.5% YoY in Q3 2025 to 23.4% in Q1 2026, and any further deceleration could trigger multiple compression. While the company is now profitable, its net margin of 3.7% is still low for a SaaS company, leaving limited room for error. The trailing P/E of 456x is extremely elevated, making the stock highly sensitive to earnings misses. Additionally, stock-based compensation remains a concern, as it dilutes shareholders and pressures GAAP earnings.
Market & Competitive Risks: HubSpot operates in a highly competitive CRM and marketing software market, facing rivals like Salesforce and other SaaS players. The broader SaaS sector has experienced a rotation away from growth stocks, as evidenced by the stock's 57.6% decline over the past year versus the S&P 500's 18.4% gain. With a beta of 1.22, HubSpot is more volatile than the market, amplifying downside risk during macro downturns. Recent news highlights a shift toward AI infrastructure stocks, further pressuring software names. Regulatory risks, such as data privacy laws, could also impact HubSpot's operations.
Worst-Case Scenario: In a severe downturn, continued revenue deceleration below 20% growth, combined with margin compression from increased competition, could drive the stock to its 52-week low of $169.63. This represents a potential 24.4% downside from the current price of $224.26. If the company fails to sustain profitability or issues disappointing guidance, analyst downgrades could push the stock even lower, possibly testing the low target of $180.00. The historical max drawdown of -70.12% suggests that in a worst-case scenario, losses could be substantial, though the current price already reflects significant pessimism.